-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S4/yAp4knQGOM6fZ0eT5+6kRoAoPSyCKZauj/ReDBjgBwvUnL2Ys9xh0J0z9NYTK Sj6BZwEZ3PKpIUU/0+GoJA== 0001104659-06-022279.txt : 20060404 0001104659-06-022279.hdr.sgml : 20060404 20060404213716 ACCESSION NUMBER: 0001104659-06-022279 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060401 FILED AS OF DATE: 20060404 DATE AS OF CHANGE: 20060404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABGENIX INC CENTRAL INDEX KEY: 0001052837 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943248826 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5106086500 MAIL ADDRESS: STREET 1: 6701 KAISER DRIVE CITY: FREMONT STATE: CA ZIP: 94555 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEE KENNETH B JR CENTRAL INDEX KEY: 0001208570 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24207 FILM NUMBER: 06740380 BUSINESS ADDRESS: STREET 1: 2808 CHELSEA CIRCLE CITY: DURHAM STATE: NC ZIP: 27707 BUSINESS PHONE: 9194934800 4 1 a4.xml 4 X0202 4 2006-04-01 1 0001052837 ABGENIX INC ABGX 0001208570 LEE KENNETH B JR 6701 KAISER DRIVE FREMONT CA 94555 1 0 0 0 Non-Qualified Stock Option (right to buy) 6.94 2006-04-01 4 D 0 40000 D 2003-03-13 2010-03-13 Common Stock, par value $0.0001 per share 40000 0 D Non-Qualified Stock Option (right to buy) 13.36 2006-04-01 4 D 0 15000 D 2004-06-07 2011-06-07 Common Stock, par value $0.0001 per share 15000 0 D Non-Qualified Stock Option (right to buy) 7.70 2006-04-01 4 D 0 20000 D 2005-06-13 2012-06-13 Common Stock, par value $0.0001 per share 20000 0 D 1/48 of the total shares subject to the option became exercisable on 3/13/2003 and an additional 1/48 of the total shares subject to the option became exercisable each full month thereafter with the balance fully vesting on 4/1/2006. This option was converted into an option to acquire 12,400 shares of Amgen Inc. common stock at an exercise price of $22.39 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 4,650 shares of Amgen Inc. common stock at an exercise price of $43.10 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. This option was converted into an option to acquire 6,200 shares of Amgen Inc. common stock at an exercise price of $24.84 per share pursuant to the terms of the Agreement and Plan of Merger, dated as of December 14, 2005, among Abgenix, Inc., Amgen Inc. and Athletics Merger Sub, Inc. /s/ George F. Fraley (Attorney-in-Fact) 2006-04-01 -----END PRIVACY-ENHANCED MESSAGE-----